Immunitybio Inc (IBRX)

CapEx to Revenue

6.91%

Quarterly · Period ending:

IBRX logo

IBRX CapEx to Revenue

Latest reported6.91%
IBRX Quarterly CapEx/Revenue (0.00% → 6.91%)
High-resolution chart · PNG

IBRX capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Immunitybio Inc CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
6.9067%
4.0424%
3.3303%
2.4173%
4.0908%
6.7869%
27.9529%
45.7255%
69.15%
3,152.5%
5,723.0216%
6,920.7317%
20,795.122%
2,341.1111%
25,932.8767%
13,504.2373%
45,568.5714%
195,335.7143%
2,667.4359%
12,169.697%
2,373.1563%
5,095.6835%
3,328.5714%
1,353.6424%
2.0642%
190.9091%
73.913%
3,441.6667%
5,794.1176%
42,080%
29,214.2857%
11,816.129%
62,300%
98,040%
95,275%
133,962.5%
58,257.1429%
40,990.9091%
9,700%
25,658.3333%
8,800%
17,783.3333%
5,814.2857%
6,720%
731.8681%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.